Matthew Ferguson
Financieel Directeur/CFO bij ELUTIA INC.
Vermogen: 349 890 $ op 30-04-2024
Actieve functies van Matthew Ferguson
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
ELUTIA INC. | Financieel Directeur/CFO | 28-09-2020 | - |
Loopbaan van Matthew Ferguson
Eerdere bekende functies van Matthew Ferguson
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Bossa Nova Robotics, Inc.
Bossa Nova Robotics, Inc. Recreational ProductsConsumer Durables Bossa Nova Robotics, Inc. designs and manufactures robotic toys. The company was founded by Sarjounin Skaff and David Palmer in Febrauary 2005 and is headquartered in Pittsburgh, PA. | Financieel Directeur/CFO | 01-09-2018 | 01-07-2020 |
AVINGER, INC. | Financieel Directeur/CFO | 01-01-2011 | 01-08-2018 |
Investor Relations Contact | 01-01-2011 | 01-08-2018 | |
President | 01-01-2011 | 01-08-2018 | |
Tethys Bioscience, Inc.
Tethys Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Tethys Bioscience was dedicated to the discovery, development and commercialization of novel biological markers biomarkers that provided a practical tool to address the growing global challenge of chronic metabolic diseases such as diabetes. By developing new tests that used protein and other blood borne biomarkers to identify people at high risk for devastating and preventable diseases, they can arm patients and physicians with knowledge they can use to help prevent disease progression. These biomarkers gave a snapshot of an individual's current risk, which may be modifiable. Their goal was to provide clinicians with an objective and convenient means to risk-stratify their patients and help them focus appropriate intervention strategies on those most likely to benefit. Their research strategies lead to sets of biomarkers that can be used to quantify the level of an individual's risk. The company had become a pioneer in the discovery, development and value creation of novel biological markers for the clinical diagnostics marketplace: The company had built expertise, created significant intellectual property, and was executing its business plan around three key areas: Biomarker Discovery, Clinical Validation and ValueCreation. It was focused upon introducing products that yield significant savings to the health care system and improve the quality of life for patients. | Financieel Directeur/CFO | 04-05-2010 | 01-12-2010 |
Proteolix, Inc.
Proteolix, Inc. Pharmaceuticals: MajorHealth Technology Proteolix, Inc. manufactures bio-pharmaceutical related products. It engages in the discovery, development, and marketing of pharmaceutical products to treat cancer and immunological conditions. The company was founded by Susan M. Molineauxf in December 2003 and is headquartered in South San Francisco, CA | Financieel Directeur/CFO | 01-01-2008 | 01-04-2009 |
FoxHollow Technologies, Inc.
FoxHollow Technologies, Inc. Medical SpecialtiesHealth Technology FoxHollow Technologies, Inc. designs, develops, manufactures, and sells medical devices for the treatment of peripheral artery disease. The company's products include Rinspirator, Seath, and SilverHawk plaque excision system. Its products are used for disposable catheter system that removes plaque and reopens blocked arteries. The company was founded by John B. Simpson in October 1996 and is headquartered in Redwood City, CA. | Comptroller/Controller/Auditor | 01-07-2002 | 01-12-2007 |
Financieel Directeur/CFO | 01-07-2002 | 01-12-2007 | |
ChannelPoint, Inc.
ChannelPoint, Inc. Insurance Brokers/ServicesFinance ChannelPoint, Inc. provides insurance services over the Internet. It also provides Internet based e-commerce solutions to the insurance industry. The company was founded in December, 1996 by Kenneth E. Hollen and is headquartered in Westminster, CO. | Financieel Directeur/CFO | 01-02-1998 | 01-01-2002 |
HP INC. | Corporate Officer/Principal | - | - |
Opleiding van Matthew Ferguson
University of California, Berkeley | Masters Business Admin |
University of Pennsylvania | Graduate Degree |
Stanford University | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 11 |
Mauritius (Eiland) | 2 |
Operationeel
Director of Finance/CFO | 7 |
Comptroller/Controller/Auditor | 1 |
Masters Business Admin | 1 |
Sectoraal
Health Technology | 6 |
Consumer Services | 4 |
Finance | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
HP INC. | Electronic Technology |
AVINGER, INC. | Health Technology |
ELUTIA INC. | Health Technology |
Bedrijven in privébezit | 5 |
---|---|
FoxHollow Technologies, Inc.
FoxHollow Technologies, Inc. Medical SpecialtiesHealth Technology FoxHollow Technologies, Inc. designs, develops, manufactures, and sells medical devices for the treatment of peripheral artery disease. The company's products include Rinspirator, Seath, and SilverHawk plaque excision system. Its products are used for disposable catheter system that removes plaque and reopens blocked arteries. The company was founded by John B. Simpson in October 1996 and is headquartered in Redwood City, CA. | Health Technology |
ChannelPoint, Inc.
ChannelPoint, Inc. Insurance Brokers/ServicesFinance ChannelPoint, Inc. provides insurance services over the Internet. It also provides Internet based e-commerce solutions to the insurance industry. The company was founded in December, 1996 by Kenneth E. Hollen and is headquartered in Westminster, CO. | Finance |
Proteolix, Inc.
Proteolix, Inc. Pharmaceuticals: MajorHealth Technology Proteolix, Inc. manufactures bio-pharmaceutical related products. It engages in the discovery, development, and marketing of pharmaceutical products to treat cancer and immunological conditions. The company was founded by Susan M. Molineauxf in December 2003 and is headquartered in South San Francisco, CA | Health Technology |
Tethys Bioscience, Inc.
Tethys Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Tethys Bioscience was dedicated to the discovery, development and commercialization of novel biological markers biomarkers that provided a practical tool to address the growing global challenge of chronic metabolic diseases such as diabetes. By developing new tests that used protein and other blood borne biomarkers to identify people at high risk for devastating and preventable diseases, they can arm patients and physicians with knowledge they can use to help prevent disease progression. These biomarkers gave a snapshot of an individual's current risk, which may be modifiable. Their goal was to provide clinicians with an objective and convenient means to risk-stratify their patients and help them focus appropriate intervention strategies on those most likely to benefit. Their research strategies lead to sets of biomarkers that can be used to quantify the level of an individual's risk. The company had become a pioneer in the discovery, development and value creation of novel biological markers for the clinical diagnostics marketplace: The company had built expertise, created significant intellectual property, and was executing its business plan around three key areas: Biomarker Discovery, Clinical Validation and ValueCreation. It was focused upon introducing products that yield significant savings to the health care system and improve the quality of life for patients. | Health Technology |
Bossa Nova Robotics, Inc.
Bossa Nova Robotics, Inc. Recreational ProductsConsumer Durables Bossa Nova Robotics, Inc. designs and manufactures robotic toys. The company was founded by Sarjounin Skaff and David Palmer in Febrauary 2005 and is headquartered in Pittsburgh, PA. | Consumer Durables |
- Beurs
- Insiders
- Matthew Ferguson
- Ervaring